BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162 | -17.3% | 4,295 | 0.0% | 0.01% | -12.5% |
| Q2 2023 | $196 | +4.8% | 4,295 | -6.9% | 0.01% | 0.0% |
| Q1 2023 | $187 | -20.4% | 4,611 | 0.0% | 0.01% | -20.0% |
| Q4 2022 | $235 | -99.9% | 4,611 | -39.5% | 0.01% | -37.5% |
| Q3 2022 | $411,000 | -67.0% | 7,623 | -60.7% | 0.02% | -56.8% |
| Q2 2022 | $1,246,000 | -53.0% | 19,401 | -43.3% | 0.04% | -41.3% |
| Q1 2022 | $2,651,000 | +20.1% | 34,190 | +33.0% | 0.06% | +40.0% |
| Q4 2021 | $2,207,000 | -29.1% | 25,712 | -33.6% | 0.04% | -35.7% |
| Q3 2021 | $3,115,000 | -57.8% | 38,732 | -57.8% | 0.07% | -51.0% |
| Q2 2021 | $7,387,000 | -6.3% | 91,761 | -1.9% | 0.14% | -9.5% |
| Q1 2021 | $7,886,000 | +53.0% | 93,499 | +45.6% | 0.16% | +49.1% |
| Q4 2020 | $5,153,000 | -4.7% | 64,221 | -4.5% | 0.11% | -15.9% |
| Q3 2020 | $5,406,000 | -11.1% | 67,225 | -4.8% | 0.13% | -17.1% |
| Q2 2020 | $6,079,000 | +57.0% | 70,600 | +48.0% | 0.15% | +40.7% |
| Q1 2020 | $3,873,000 | -8.5% | 47,705 | -5.7% | 0.11% | +18.7% |
| Q4 2019 | $4,232,000 | -8.1% | 50,608 | -3.9% | 0.09% | -13.3% |
| Q3 2019 | $4,605,000 | -65.2% | 52,647 | -67.4% | 0.10% | -64.2% |
| Q2 2019 | $13,224,000 | -6.1% | 161,460 | -6.8% | 0.29% | -5.5% |
| Q1 2019 | $14,079,000 | +24.4% | 173,156 | +0.7% | 0.31% | +9.9% |
| Q4 2018 | $11,319,000 | -21.8% | 171,972 | -8.5% | 0.28% | -1.4% |
| Q3 2018 | $14,483,000 | +1.8% | 187,874 | -2.5% | 0.29% | -2.1% |
| Q2 2018 | $14,230,000 | -22.6% | 192,720 | -31.8% | 0.29% | -20.2% |
| Q1 2018 | $18,391,000 | +0.0% | 282,760 | -0.6% | 0.37% | +0.3% |
| Q4 2017 | $18,389,000 | +33.0% | 284,486 | +29.1% | 0.36% | +18.9% |
| Q3 2017 | $13,823,000 | +1.9% | 220,281 | -1.7% | 0.31% | +5.9% |
| Q2 2017 | $13,567,000 | +14.2% | 224,098 | -2.2% | 0.29% | +11.1% |
| Q1 2017 | $11,879,000 | +56.1% | 229,063 | +33.5% | 0.26% | +46.6% |
| Q4 2016 | $7,609,000 | -23.0% | 171,617 | -17.3% | 0.18% | -13.2% |
| Q3 2016 | $9,883,000 | – | 207,619 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |